3billion

IPO

Ending the diagnostic odyssey for rare disease patients.

Seoul, South Korea · Founded 2016 · $13.0M raised

Headquarters
Seoul
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$13.0M
Last Round
$13.0M Series CJan 2024
Rounds
1

About

3billion is a South Korean AI-driven genetic diagnostics company specializing in rare disease testing. Founded in 2016, the company offers comprehensive exome and genome sequencing with unlimited reanalysis — continuously updating results as new diseases are discovered — to reduce the diagnostic odyssey faced by rare disease patients worldwide. Its customers are clinical geneticists, hospital rare disease centers, and patients globally; it has partnered with Seoul National University Hospital and has operations in the United States. 3billion listed on the KOSDAQ exchange in November 2024.

Summary

3billion is an Artificial Intelligence company based in Seoul, South Korea, founded in 2016. It has raised $13.0M in total across 1 round, most recently a $13.0M Series C round in Jan 2024. Investors include Wells Investment, Korean Development Bank and D3 Jubilee Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPONov 2024
$10.3M

Sign up to see all 2 rounds

Series C through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

3billion on Indexed.vc
<a href="https://indexed.vc/companies/3billion"><img src="https://indexed.vc/api/badge/company/3billion" alt="3billion on Indexed.vc" width="260" height="76" /></a>